CA2647843A1 - Detection of proteins from circulating neoplastic cells - Google Patents

Detection of proteins from circulating neoplastic cells Download PDF

Info

Publication number
CA2647843A1
CA2647843A1 CA002647843A CA2647843A CA2647843A1 CA 2647843 A1 CA2647843 A1 CA 2647843A1 CA 002647843 A CA002647843 A CA 002647843A CA 2647843 A CA2647843 A CA 2647843A CA 2647843 A1 CA2647843 A1 CA 2647843A1
Authority
CA
Canada
Prior art keywords
protein
cancer cells
immunoassay
detecting
egfr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002647843A
Other languages
English (en)
French (fr)
Inventor
Robert M. Lorence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellstat Biologics Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2647843A1 publication Critical patent/CA2647843A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002647843A 2006-04-18 2007-04-18 Detection of proteins from circulating neoplastic cells Abandoned CA2647843A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74501606P 2006-04-18 2006-04-18
US60/745,016 2006-04-18
PCT/US2007/066857 WO2007121465A2 (en) 2006-04-18 2007-04-18 Detection of proteins from circulating neoplastic cells

Publications (1)

Publication Number Publication Date
CA2647843A1 true CA2647843A1 (en) 2007-10-25

Family

ID=38610457

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002647843A Abandoned CA2647843A1 (en) 2006-04-18 2007-04-18 Detection of proteins from circulating neoplastic cells

Country Status (6)

Country Link
US (1) US8012480B2 (https=)
EP (1) EP2008102A4 (https=)
JP (1) JP5025724B2 (https=)
CA (1) CA2647843A1 (https=)
MX (1) MX2008013332A (https=)
WO (1) WO2007121465A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080261243A1 (en) * 2004-10-06 2008-10-23 Wellstat Biologics Corporation Detection of Elevated Levels of Her-2/Neu Protein on Circulating Cancer Cells and Treatment
CA2684265A1 (en) * 2007-04-19 2008-10-30 Wellstat Biologics Corporation Detection of elevated levels of her-2/neu protein from non-isolated circulating cancer cells and treatment
EP3043181B1 (en) 2008-01-15 2020-04-08 The Board of Trustees of the Leland Stanford Junior University Markers of acute myeloid leukemia stem cells
ES2582340T3 (es) 2008-01-15 2016-09-12 The Board Of Trustees Of The Leland Stanford Junior University Métodos para manipular fagocitosis mediada por CD47
US11072655B2 (en) 2008-01-15 2021-07-27 The Board Of Trustees Of The Leland Stanford Junior University Markers of acute myeloid leukemia stem cells
WO2011162904A2 (en) * 2010-05-24 2011-12-29 Marek Malecki Multidomain biotags for cancer detection, diagnosis and therapy and methods of their use priority statement
JP5960146B2 (ja) * 2010-10-14 2016-08-02 ジャンセン ダイアグノスティックス，エルエルシー 多特異性捕捉試薬及び混合検出試薬を用いる膵臓患者の循環腫瘍細胞を検出する方法及びキット
CN102680456B (zh) 2011-03-16 2015-07-08 北京联众泰克科技有限公司 一种电化学发光免疫测定方法
EP2726870B1 (en) 2011-06-29 2018-10-03 Academia Sinica The capture, purification and release of biological substance using a surface coating
WO2013036620A1 (en) * 2011-09-06 2013-03-14 Becton, Dickinson And Company Methods and compositions for cytometric detection of rare target cells in a sample
WO2014147631A1 (en) 2013-03-22 2014-09-25 Natco Pharma Limited Formulation comprising gefitinib as oral suspension
TW201623605A (zh) 2014-04-01 2016-07-01 中央研究院 用於癌症診斷及預後之方法及系統
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
EP3194616B1 (en) * 2014-09-18 2020-07-29 AdnaGen GmbH Mrna and/or protein of ercc1 isoform 3 for use in diagnosing a resistance against a therapeutic agent and method for diagnosing a resistance against a therapeutic agent using said mrna and/or protein
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
CN109991410B (zh) * 2017-12-29 2022-07-05 上海白泽医学检验所有限公司 一种含抗cd45单抗的组合物及其使用方法
CN114487059B (zh) * 2021-12-29 2022-11-25 苏州大学 一种电化学发光免疫传感器及其制备和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005264A1 (en) * 1989-09-29 1991-04-18 Oncogenetics Partners Detection and quantification of neu related proteins in the biological fluids of humans
CA2223027A1 (en) * 1995-06-07 1996-12-19 Igen, Inc. Electrochemiluminescent enzyme immunoassay
US6960449B2 (en) 1999-02-10 2005-11-01 Cell Works Diagnostics, Inc. Class characterization of circulating cancer cells isolated from body fluids and methods of use
US7537938B2 (en) * 2000-04-28 2009-05-26 Monogram Biosciences, Inc. Biomarker detection in circulating cells
EP1360496A4 (en) * 2001-02-16 2005-03-09 Immunivest Corp METHOD AND REAGENTS FOR THE QUICK AND EFFICIENT INSULATION OF CIRCULATING CANCER CELLS
JP2005507997A (ja) * 2001-10-26 2005-03-24 イムニベスト・コーポレイション 同一試料についての包括的核酸および形態学的特徴のマルチパラメーター分析
DE60331310D1 (de) * 2002-06-26 2010-04-01 Univ Louisville Res Found Verfahren zum apoptosenachweis
WO2004008099A2 (en) * 2002-07-15 2004-01-22 Genentech, Inc. METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES
EP1613205B1 (en) * 2003-04-01 2013-04-24 Monogram BioSciences, Inc. Erbb surface receptor complexes as biomarkers
AU2004264948A1 (en) * 2003-08-15 2005-02-24 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Multifactorial assay for cancer detection
ES2537631T3 (es) * 2004-05-27 2015-06-10 The Regents Of The University Of Colorado Métodos para la predicción del resultado clínico para inhibidores del receptor del factor de crecimiento epidérmico para pacientes de cáncer
WO2006031843A2 (en) 2004-09-14 2006-03-23 John Wayne Cancer Institute Detection of cancer cells in body fluids
US20080261243A1 (en) * 2004-10-06 2008-10-23 Wellstat Biologics Corporation Detection of Elevated Levels of Her-2/Neu Protein on Circulating Cancer Cells and Treatment

Also Published As

Publication number Publication date
MX2008013332A (es) 2008-11-10
EP2008102A2 (en) 2008-12-31
JP5025724B2 (ja) 2012-09-12
WO2007121465A2 (en) 2007-10-25
EP2008102A4 (en) 2009-07-08
US20090098138A1 (en) 2009-04-16
WO2007121465A3 (en) 2008-06-19
WO2007121465B1 (en) 2008-09-12
JP2009534667A (ja) 2009-09-24
US8012480B2 (en) 2011-09-06

Similar Documents

Publication Publication Date Title
US8012480B2 (en) Detection of proteins from circulating neoplastic cells
EP1797431B1 (en) Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment
US20090291920A1 (en) Detection of steroid receptors on circulating carcinoma cells and treatment
US20100120072A1 (en) Detection of elevated levels of her-2/neu protein from non-isolated circulating cancer cells and treatment
US9057055B2 (en) Method of obtaining circulating cancer cell populations
EP2008103B1 (en) Detection of circulating endothelial cells
US20210231659A1 (en) Detection and isolation of myeloid-derived suppressor cell subpopulations
US20140302526A1 (en) Zap-70 detection in chronic lymphocytic leukemia
TWI727132B (zh) 肺癌幹細胞之生物標誌
HK1103439B (en) Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment
HK1123358B (en) Detection of circulating endothelial cells

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140422